CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

BackgroundRelapsed or refractory (R/R) Burkitt lymphoma (BL) in adults is aggressive and lacks standardized salvage options. Data on the efficacy and safety of chimeric antigen receptor T (CAR-T) cell therapy in this population remains limited.MethodsWe retrospectively analyzed 25 adult patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui Liu, Fan Yang, Lixia Ma, Yuelu Guo, Miaomiao Cao, Zhonghua Fu, Biping Deng, Qinlong Zheng, Chen Chen, Danyang Li, Xiaoyan Ke, Kai Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
Burkitt lymphoma (BL)
car-t
Allo-HSCT
allogeneic hematopoietic stem cell transplantation
auto-HSCT
mutation - genetics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1566938/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1566938/full

Similar Items